# NextPoint

**Canonical:** https://apis.io/providers/nextpoint/  
**Website:** https://nextpointtx.com/  
**APIs profiled:** 0

NextPoint Therapeutics, Inc. is a clinical-stage immuno-oncology biotechnology company headquartered at 238 Main Street, Cambridge, Massachusetts. Founded in 2019-2020 out of MPM Capital on discoveries by Gordon Freeman (Dana-Farber Cancer Institute) and XingXing Zang (Albert Einstein College of Medicine), it develops first-in-class precision therapeutics against the B7-H7/HHLA2 - KIR3DL3 immune checkpoint axis, combining direct tumor-cell killing with immunomodulation in a single molecule. Its pipeline spans three modalities - NPX887, an anti-B7-H7 monoclonal antibody with TMIGD2 co-stimulation and enhanced ADCC currently in Phase 1; NPX372, a 2:1 bispecific B7-H7 x CD3 T cell engager; and NPX125, a DAR8 antibody drug conjugate - all guided by a biomarker-driven patient selection strategy. Investors include Leaps by Bayer, Sanofi Ventures, MPM BioImpact, Catalio Capital, Dana-Farber, Invus, Arkin, Simcere, SixtyDegree and Pagoda Tree; its shares trade on private secondary marketplaces. It is a therapeutics developer rather than a software company and publishes no API, SDK, developer program or machine-readable specification.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-09-02 under rubric 0.18.0. Trend: flat (+0.0 from 3.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Nextpoint Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Oncology, Immunotherapy, Precision Medicine, Clinical Stage, Drug Development, Healthcare, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/nextpoint/). Scores are computed from the provider's own public artifacts under a published rubric.